Showing results (4071-4080 of 6,973) with videos related to

Sort By:
Pageof 698
Histopathology|November 1, 1996
Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomasR Kushima, B Lohe, F Borchard
Histopathology|November 1, 1996
The site of inhibin production in ovarian neoplasmsP Flemming, W Grothe, H Maschek, et al.
Histopathology|May 1, 1987
Oncocytic liver cell adenomaJ R Salisbury, B C Portmann
Histopathology|November 2, 2018
Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breastJoshua Li, Wai-Yee Ho, Julia Y S Tsang, et al.
Histopathology|October 31, 2018
Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysisCristina Graham Martínez, Nikki Knijn, Marcel Verheij, et al.
Histopathology|July 1, 1987
Human lung tumours: does intermediate filament co-expression correlate with other morphological or immunocytochemical features?K C Gatter, M S Dunnill, A Heryet, et al.
Histopathology|April 19, 2017
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinomaFelipe C Geyer, Fresia Pareja, Kathleen A Burke, et al.
Histopathology|April 19, 2017
Molecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomasBasile Tessier-Cloutier, Karama Asleh-Aburaya, Varsha Shah, et al.
Histopathology|November 20, 2016
Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 lossKento Misumi, Akimasa Hayashi, Junji Shibahara, et al.
Histopathology|November 20, 2016
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based studyKin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, et al.
Pageof 698